NanoString’s GeoMx MWT Atlas Expands Spatial Genomics Leadership

In an age where your genomic makeup can be stored on a USB stick, digital genome technology has become an important tool for the healthcare sector.

Digital genome technology can help us unravel some of the most pressing concerns affecting the healthcare sector at present.

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/1125 The growing prevalence of neurodegenerative diseases among the geriatric population is likely to be a major driver for the global digital genome market.

By application, the market has been segmented into drug discovery, agriculture & animal research, diagnostics, personalized medicine, academic research and others.Regional Analysis:Geographically, the global digital genome market is segmented into four major regions such as Americas, Asia Pacific, Europe and the Middle East and Africa.

The skyrocketing demand for personalized medication and targeted therapy in the Europe region is fueling the growth of the digital genome market in this region.

Whereas, the Asia Pacific region is anticipated to witness significant growth in the global digital genome market owing to the rapid development in the field of biotechnology and rising healthcare spending in this region.The Middle East and Africa region accounts for the least share in the global digital genome market owing to the poor primary healthcare services and low penetration of advanced technology in the healthcare sector in various underdeveloped areas of this region.Competitive Analysis:Leading players in the global digital genome market include Umbel, BiogeniQ, GenomeMe, NanoString, and Illumina Inc.

COVID-19 Impact Analysis on Single-Cell Multiomics Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.

Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the single-cell multiomics market include Bio-Rad Laboratories, BGI Genomics Co. Ltd., Cytiva Life Science, Fluidigm Corporation, Illumina, Inc., 10x Genomics, NanoString Technologies, MissionBio, QIAGEN N.V., and Takara Bio.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Single-Cell Multiomics Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/single-cell-multiomics-market/download-sampleMarket DynamicsThe rising burden of infectious, chronic, & life-threatening diseases, growing biotechnology & pharmaceutical research, and advancement & development in the next-generation sequencing techniques for the diagnosis are factors propelling demand for single-cell multiomics.

Increasing funding for life science research, rising adoption of personalized medicine for screening and diagnostics of genetic disorders, and the outbreak of the COVID-19 pandemic offer unprecedented opportunities for market growth.

However, the high cost associated with single-cell multiomics, lack of skilled professionals, and integration of data & limited availability of ample online data storage & analysis platforms are likely to restrain the market's growth.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.

A microRNA is a tiny non-coding RNA molecule that is found in animals, plants as well as some viruses, that is utilized in post-transcriptional regulation of gene expression and RNA silencing. The overall market is likely to account for a robust growth owing to growing demand for microRNA re-agents in addition to kits for a range of applications which could in due course interpret into initial innovative therapeutic solutions for different difficult to cure illnesses. In terms of value, it is estimated to record a CAGR of 7.9% during the eight-year calculated period 2025. 

Report For Sample with Table of Contents@ https://www.researchreportinsights.com/report/sample/110114980/MicroRNA-Market

Market Segmentation

Based on assay type, the overall market is segmented into miRNA Arrays, PCR-based assay, next-generation sequencing (NGS) and immune assay (which is further categorized into colorimetric assays, fluorescent assays and chemiluminescent assays). PCR based arrays segment will be accounting for 36.9% by the end of 2025, followed by next-generation sequencing segment and is estimated to record an 8.1% CAGR throughout the projection period.

The application of the microRNA is mainly into research and clinical diagnostics. The research segment is considered as the biggest in the overall market by accounting for about US$ 525.6 Million by the end of 2025, up from US$ 275.7 Million in the year 2017. It is also expected to record an 8.4% CAGR over the calculated period.

The end users of the microRNA include biopharmaceutical companies, academic and research institutes, diagnostic centers and contract research organizations. The academic & research institutes are the most lucrative segment in overall microRNA market, it is expected to be accounting for about US$ 255.9 Million by the end of the forecast year 2025, up from US$ 138.9 Million in 2017 in terms of value. It is projected to register a CAGR of 7.9% throughout 2017-2025.

On the basis of region, the overall market is studied across five key regions including Latin America, North America, Asia Pacific, Europe and Middle East & Africa. North America is considered to be the most lucrative region among other regions and is likely to reach US$ 245.9 Million by 2025, exhibiting a 7.3% CAGR during 2017-2025, followed by Europe.

Request For Report Discount@ https://www.researchreportinsights.com/report/discount/110114980/MicroRNA-Market

Key Market Players

The overall market for microRNA has at present the following prominent players 

• Agilent Technologies

• F. Hoffmann-La Roche Ltd

• Illumina, Inc.

• Sigma Aldrich Corp.

• Thermo Fisher Scientific, Inc.

• Qiagen N.V

• Rosetta Genomics Ltd.

• HTG Molecular Diagnostics, Inc.

• Bio-Rad Laboratories Inc.

• Dharmacon, a Horizon Discovery Group Co.

• System Biosciences LLC

• Bioline GmbH (A Meridian Life Science Company)

• Miltenyi Biotec

• BioVendor — Laboratorní medicína a.s.

• Abcam Plc

• New England Biolabs, Inc.

• Kaneka Corporation (Eurogentec)

• Promega Corporation

• GeneCopoeia, Inc.

• NanoString Technologies, Inc

Report Analysis@ https://www.researchreportinsights.com/report/rd/110114980/MicroRNA-Market

Circulating Tumor Cell Market OverviewIn 2017, the global market size of circulating tumor cell (CTC) reached a valuation of USD 9,393.1 Mn.

The market is projected to surpass a valuation of USD 28,300 Mn by the end of 2023, reflecting a healthy growth rate.The prevalence rate of CTC has gone up in recent years.

The mechanism of CTC is responsible for a vast majority of deaths caused by cancer.

Circulating tumor cells can be associated with different types of cancer prognosis including breast cancer, prostate cancer, and gastric cancer among others.

Healthcare companies continue to focus on developing solutions that enable accurate and quick detection of CTC.

The diagnosis and analysis of CTCs can help in early cancer detection and determine appropriate treatments tailored for specific cancer types.The “Circulating Tumor Cell Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.The Circulating Tumor Cell Market provide valuable insight with an emphasis on the global market including some of the major players such As, Ikonisys Inc., Greiner Bio-One International GmbH, Thermo Fisher Scientific, SRI International, STEMCELL Technologies, Miltenyi Biotec, Menarini Silicon Biosystems, QIAGEN Hannover (QIAGEN), F. Hoffmann-La Roche Ltd, NanoString Technologies, Inc, Fluxion Biosciences, Inc., GE Healthcare, ApoCell, Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation), Epic Lifesciences, Celltraffix Inc.Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region.

According to the new market research report “Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User – Global Forecasts to 2025” published by MarketsandMarkets™.The Single-cell Analysis Market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast periodRecent Developments in Industry:In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been developed for consolidated targeted DNA and RNA enrichment and analyses.

These panels save time and conserve samples that are of limited availability.In July 2019, QIAGEN partnered with Illumina with the aim to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits.In June 2019, Beckman Coulter acquired Cytobank, Inc. (US) to integrate Cytobank’s software into Beckman Coulter’s product portfolio to provide innovative solutions to customers.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254Prominent players in this market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).

These players adopted the strategies of partnerships, agreements, and acquisitions to expand their presence in the global single-cell analysis market.Becton, Dickinson and Company held the leading position in the global single-cell analysis market in 2018.

The company adopts the strategies of product launches and collaborations in order to offer innovative solutions and sustain its leading position in the market.

It also focuses on offering solutions and technologies to the research community in order to assist scientists and researchers by developing and manufacturing high-quality diagnostic and imaging products.Danaher Corporation held the second position in the global single-cell analysis market in 2018.

The company offers a broad range of products in the single-cell analysis market, including flow cytometers, cell counters, mass spectrometers, reagents, and kits.

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Cancer Profiling market during the historical period of 2013 – 2017.

The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2018, and key prospects over the forecast period 2018 – 2028.According to the report, the cancer profiling market is projected to grow at 4.7% CAGR through 2028.

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Cancer Profiling market, both at global and regional levels.

The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Cancer Profiling market.After reading the Cancer Profiling market report, readers get insight into: Major drivers and restraining factors, opportunities and challenges, and the competitive landscapeNew, promising avenues in key regionsNew revenue streams for all players in emerging marketsFocus and changing role of various regulatory agencies in bolstering new opportunities in various regionsDemand and uptake patterns in key industries of the Cancer Profiling marketNew research and development projects in new technologies in key regional marketsChanging revenue share and size of key product segments during the forecast periodTechnologies and business models with disruptive potential Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S_id=358The Cancer Profiling market report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period.

Key regions covered comprise: North America (U.S., Canada)Latin America (Brazil, Mexico, Argentina, Rest of Latin America)Europe (Germany, Italy, France, U.K., Spain, Benelux, Russia, Rest of Europe)JapanAPEJ (China, India, Indonesia, Thailand, Singapore, Australia & New Zealand, Rest of Asia Pacific)MEA (GCC Countries, Turkey, Northern Africa, South Africa, Rest of Middle East & Africa)The evaluation of the competitive landscape in the Cancer Profiling market covers the profile of the following top players:Hoffmann La Roche Ltd, Illumina Inc, QIAGEN, Thermo Fisher Scientific Inc, Abbott, Nanostring Technologies Inc,  Siemens AG, HTG Molecular Diagnostics, Inc, Perkin Elmer Inc, Agilent Technologies Inc, Negenomics Laboratory Inc, Genomic Health, Biogenex and Pacific Biosciences of California, Inc.To expand the understanding of opportunities in the global Cancer Profiling market report looks at close quarters into the opportunities and new avenues in following key segments: HospitalsDiagnostic CentersCancer Research InstitutesOthersIn addition to understanding the demand patterns of various end users, the report on the Cancer Profiling market also enumerates trends expected to attract investments by other various associated industries.On the basis of product types, the Cancer Profiling market report offers insight into major adoption trends for the following segments:InstrumentsConsumablesBy Indication,Breast CancerColorectal CancerOvarian CancerMelanomaKidney CancerLung Cancer (including NSCLC)Rare CancersThe global Cancer Profiling market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period.

In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.For More Detailed Information about Methodology @ https://www.factmr.com/connectus/sample?flag=RM_id=358Some important questions that the Cancer Profiling market report tries to answer exhaustively are: Key strategic moves by various players in the Cancer Profiling market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares.Which strategies will enable top players in the Cancer Profiling market to expand their geographic footprints?Which new business models are expected to change the course of growth of key regional markets in near future?Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants?Which products segments have in recent years have seen new, lucrative application areas?What are COVID-19 implication on Cancer Profiling market and learn how businesses can respond, manage and mitigate the risks?Media Release:  https://www.factmr.com/media-release/802/global-cancer-profiling-market

 The “Global Precision Medicine Diagnostics  Market Evaluation for 2025" is a skilled and comprehensive study of this sector with a unique focus on international market trend evaluation.

This report offers trends and opportunities and offers statistics in the marketplace standing of market players.Key Player Mentioned: Intomics, Ferrer Incode, Nanostring Technologies, Tepnel Pharma Services, Pfizer, Novartis, Teva Pharmaceuticals, Merck & Co., Qiagen, Quest DiagnosticsRequest Sample Copy @t: https://introspectivemarketresearch.com/request-samples.php?_id=9&_sid=9035Informative data about Precision Medicine Diagnostics  Market has been published.

It covers different aspects of companies and to spice up the performance of the businesses .

It focuses on recent developments from top level industries, which helps to supply the rules for growth of the industries.Product Segment Analysis: Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, Big Data AnalyticsApplication Segment Analysis: Oncology, CNS, Hematology, Respiratory, Immunology, OthersRegional Segment Analysis: North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.

), Asia-Pacific (China; India; Japan; Southeast Asia etc.

Geographical analysis also covers regional factors which will impede growth within the coming years.

 The Cancer Tumor Profiling Market research report is a comprehensive and vital document encompassing business strategies, qualitative and quantitative analysis, and emerging trends of the global Cancer Tumor Profiling market.

The report offers in-depth research and assessment of the key elements of the global Cancer Tumor Profiling market.

The research analysts have formulated this report through thorough primary and secondary research with a detailed analysis of the drivers, restraints, challenges, trends, and opportunities to provide a panoramic view of the Cancer Tumor Profiling market.Cancer Tumor Profiling market's growth is attributed to the increasing use of biomarkers in cancer profiling, eventually rising adoption of proteomic methods for biomarker research, thus helping to increase the drug development process over the estimated period.

The growing demand for cancer tumor profiling is driving the market for the estimated period.For more details@ https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-marketThe competitive landscape of the report has been formulated by considering all the vital parameters such as company profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial standing, market position, and expansion plans.

The report also discusses in detail the recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among others.

The report also sheds light on the recent technological developments and product advancements in the Cancer Tumor Profiling market.Furthermore, the report provides details about the new players entering the market, entry-level barriers and offers strategic recommendations to overcome those barriers to gain a substantial industry presence.Key Players operating in the industry are:Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others.Request a discount on the report @ https://www.emergenresearch.com/request-discount/50The Global Cancer Tumor Profiling Market is further analyzed across the key geographical locations where the market has expanded to a significant size.

Global Precision Oncology Market Forecast to 2027 Precision Oncology Market Report is a comprehensive study that offers in-depth details about the Precision Oncology market.

Analysis of the Global Precision Oncology Market includes a market-based outline and provides detail about the current and futuristic outlook of the market.The global Precision Oncology market research report is a comprehensive study of the industry and has been recently added by Reports and Data to its extensive database.

This informative research report is furnished with the latest happenings of the world in regards to the coronavirus pandemic.

The report provides a detailed analysis of the impact of the pandemic and the economic scenario of the industry.

The present and future impacts of the COVID-19 pandemic on the overall market are also covered in the report.Get a Free Sample PDF Report to understand our report before you purchase @ https://www.reportsanddata.com/sample-enquiry-form/3353Top players operating in the market and profiled in this report are Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc. NeoGenomics, Novartis AG, Pfizer Inc., QIAGEN, Tepnel Pharma Services, Teva Pharmaceuticals Industries Ltd, among others.For the purpose of this report, Reports and Data have segmented into the global Precision Oncology market on the basis of End-user, Technology Type, Application, and region:End-user Outlook (Revenue, USD Billion; 2017-2027)Pharmaceuticals CompaniesBiotechnology CompaniesDiagnostic CompaniesHealthcare Data CompaniesTechnology Type Outlook (Revenue, USD Million; 2017-2027)Big data AnalyticsBioinformaticsGene SequencingDrug DiscoveryCompanies DiagnosticsApplication Outlook (Revenue, USD Billion; 2017-2027)ConsumableInstrumentsServicesKey questions addressed in the report are: What is the estimated market size and share in the forecast period?What are the key driving factors of the Global Precision Oncology market?What are the risks and challenges the companies will have to face in the forecast period?What are the emerging trends and how they influence market growth?What are the opportunities for expansion of the global Precision Oncology market?Which region is expected to dominate the market during the forecast period?The report covers extensive analysis of the regions where the industry operates.

Research analysts have formulated this report through extensive primary and secondary research on the regional segmentation.The report offers a panoramic view of the competitive landscape of the Global Precision Oncology Market.

Transcriptomics Market Report presents the conceptual study and strategic analysis which provides market scope, applications, a topographical presence that drive the Transcriptomics market.

Transcriptomics Market Global Industry report provides the latest market statistics, industry growth, size, share, trends, as well as driving factors.

The detailed overview of the market segments, product description, Transcriptomics applications is presented in this report.

The rise in the biomedical research is escalating the growth of transcriptomics market.

Request Sample of Transcriptomics Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transcriptomics-market  Major Players covered in the Transcriptomics Market-Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, Thermo Fisher Scientific, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome (subsidiary of Illumina, Inc.), GENERAL ELECTRIC COMPANY, Siemens, QIAGEN, Merck KGaA, Kapa Biosystems, Spatial Transcriptomics, and NanoString Technologies, Inc. Healthcare Infrastructure Growth Installed Base and New Technology PenetrationThe transcriptomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transcriptomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transcriptomics market.

This study also analyzes the market status, future trends, revenue generation, market share, growth rate, opportunities and challenges, sales volume, market drivers, market restraints, risks, and entry barriers.

The new Single-Cell Multiomics Market report offers a comprehensive study of the current scenario of the market including major market dynamics.

Also, it highlights the in-depth marketing research with the newest trends, drivers, and segments with reference to regional and country.

Further, this report profiles top key players and analyze their market share, strategic development, and other development across the world.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the single-cell multiomics market include Bio-Rad Laboratories, BGI Genomics Co. Ltd., Cytiva Life Science, Fluidigm Corporation, Illumina, Inc., 10x Genomics, NanoString Technologies, MissionBio, QIAGEN N.V., and Takara Bio.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Single-Cell Multiomics Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/single-cell-multiomics-market/download-sampleMarket DynamicsThe rising burden of infectious, chronic, & life-threatening diseases, growing biotechnology & pharmaceutical research, and advancement & development in the next-generation sequencing techniques for the diagnosis are factors propelling demand for single-cell multiomics.

Increasing funding for life science research, rising adoption of personalized medicine for screening and diagnostics of genetic disorders, and the outbreak of the COVID-19 pandemic offer unprecedented opportunities for market growth.

Market Analysis and Insights:- Global Microscopy-based RNA Imaging Techniques MarketGlobal Microscopy-based RNA Imaging Techniques Market By Technology (smFISH, Padlock Probes/Rolling Circle Amplification, Branched DNA Probes), End-Use (Translation Research, Academic Customers, Diagnostic Customers, Pharmaceutical Manufacturer), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026Market Analysis: Global Microscopy-based RNA Imaging Techniques MarketGlobal microscopy-based RNA imaging techniques market is expected to register a substantial CAGR in the forecast period of 2019-2026.

This rise in market value can be attributed to the growing application areas of this technique.Market Definition: Global Microscopy-based RNA Imaging Techniques MarketMicroscopy-based RNA imaging techniques is technology belonging to spatial transcriptomics, wherein RNA is visualized through microscopes under specified conditions helping in enhancing the understanding of RNA in the human body which can subsequently help in better research studies and development of various healthcare products.Get More Insight About the Global Microscopy-based RNA Imaging Techniques Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microscopy-based-rna-imaging-techniques-market  Market DriversEstablishment of various market players dealing in these technologies; this factor is expected to drive the growth of the marketIncreasing utilization of spatial techniques for cancer research and diagnosis also propels the market growthIncreasing applicable benefits of transcriptomic techniques for single-cell researches over conventional techniques drives the market growthMarket RestraintsLack of preference in adoption of these technologies; this factor is expected to restrict the growth of the marketEstablished devices and techniques in various applications for conventional genomic and transcriptomics techniques; this factor is expected to restrict the growth of the marketSegmentation: Global Microscopy-based RNA Imaging Techniques MarketBy TechnologySingle Molecule RNA Fluorescence In-Situ Hybridization (smFISH)Padlock Probes/Rolling Circle AmplificationBranched DNA ProbesBy End-UseTranslation ResearchAcademic CustomersDiagnostic CustomersPharmaceutical ManufacturerBy GeographyNorth AmericaU.S.CanadaMexicoEuropeGermanyItalyU.K.FranceSpainNetherlandsBelgiumSwitzerlandTurkeyRussiaRest of EuropeAsia-PacificJapanChinaIndiaSouth KoreaAustraliaSingaporeMalaysiaThailandIndonesiaPhilippinesRest of Asia-PacificSouth AmericaBrazilRest of South AmericaMiddle East and AfricaSouth AfricaRest of Middle East and AfricaKnow More About this Report @ https://www.databridgemarketresearch.com/reports/global-microscopy-based-rna-imaging-techniques-market Key Developments in the Market:In May 2018, Seven Bridges Genomics announced that they had expanded their service offerings and capabilities by introducing spatial transcriptomics on their platform.

This availability is designed to meet the growing demand of single-cell analysis and identification and the benefits offered by spatial transcriptomics over genomicsIn March 2016, Horizon Discovery Group plc announced the launch of “HDx FFPE RNA Fusion Reference Standards”, standardizations designed to optimize and validate the various RNA-based techniques such as RNA-sequencing, endpoint RT-PCT or RT-qPCR assaysCompetitive Analysis:Global microscopy-based RNA imaging techniques market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

The report includes market shares of microscopy-based RNA imaging techniques market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Key Market Competitors:Few of the major competitors currently working in the global microscopy-based RNA imaging techniques market are Nikon Instruments Inc.; NanoString Technologies, Inc.; 10x Genomics; CARTANA AB; Horizon Discovery Group plc; Illumina, Inc.; Seven Bridges Genomics; Advanced Cell Diagnostics, Inc.; READCOOR, INC.; AAT Bioquest, Inc.; Thermo Fisher Scientific Inc.; PerkinElmer Inc. among others.Research Methodology: Global Microscopy-based RNA Imaging Techniques MarketData collection and base year analysis is done using data collection modules with large sample sizes.

The market data is analysed and forecasted using market statistical and coherent models.

Also market share analysis and key trend analysis are the major success factors in the market report.